Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Feb 26, 2020
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
General Notices
- Notice of Informational Webinar on New NIGMS Funding Announcements for Team Science and Biomedical Technology Development and Dissemination Centers
National Institute of General Medical Sciences
- Notice of Pre-Application Technical Assistance Webinar for RFA-MD-20-006, Research Centers in Minority Institutions (RCMI) (U54 Clinical Trials Optional)
National Institute on Minority Health and Health Disparities
- Announcement of the NCATS Rare Diseases Are Not Rare! Challenge Prize Competition
National Center for Advancing Translational Sciences
- Request for Information (RFI): Scientific Priorities for Behavioral and Social Science Research at NIH
Office of Behavioral and Social Sciences Research
Notice of Changes to Funding Opportunities
- Notice to Update Eligibility for the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed) PAR-19-144
National Institute of Dental and Craniofacial Research
- Notice to Update Eligibility for the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Independent Basic Experimental Studies with Humans Required) PAR-19-141
National Institute of Dental and Craniofacial Research
- Notice to Update Eligibility for the NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00-Clinical Trial Required) PAR-18-432
National Institute of Dental and Craniofacial Research
- Notice of Change to the Application Due Date for RFA-FD-20-009 titled "Drug Development Tools Research Grants (U01 Clinical Trial Optional)"
Food and Drug Administration
- Notice of Correction to RFA-MH-18-706, Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required)
National Institute of Mental Health
Notices of Special Interest
- Notice of Special Interest: Availability of Administrative Supplements to Promote Innovation in NCCIH Grants
National Center for Complementary and Integrative Health
- Notice of Special Interest (NOSI): NCI SBIR Administrative Supplements for Activities to Accelerate the Development and Commercialization of Cancer-Related Innovations
National Cancer Institute
- Notice of Special Interest (NOSI): Research on Oral Anticancer Agents in the Contexts of Utilization, Adherence, and Health Care Delivery
National Cancer Institute
- Notice of Special Interest (NOSI): Administrative Supplements for NCI Cohort Consortium Projects
National Cancer Institute
- Notice of Special Interest (NOSI): The HIV-HCV-Substance Use Disorder Syndemic: Therapeutic Approaches
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): Defining Mechanisms of Disease Recurrence in Dental, Oral, and Craniofacial Tissues
National Institute of Dental and Craniofacial Research
- Notice of Special Interest (NOSI): Availability of Administrative Supplements to Support Undergraduate Summer Research Experiences
National Institute of General Medical Sciences
- Notice of Special Interest (NOSI): Administrative Supplements for Curriculum or Training Modules to Enhance Undergraduate Biomedical Research Training
National Institute of General Medical Sciences
- Notice of Special Interest (NOSI): Administrative Supplements to Enhance Program Evaluation Capacity
National Institute of General Medical Sciences
- Notice of Special Interest (NOSI): Availability of Administrative Supplements for NNLM All of Us Community Engagement Center and the All of Us Training and Education Center.
National Library of Medicine
- Notice of Special Interest: Research through NCATS Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Awards (U01 and R21)
National Center for Advancing Translational Sciences
Funding Opportunities
- Shared Instrumentation for Animal Research (SIFAR) Grant Program (S10 Clinical Trial Not Allowed)
Limited to one application per institution – University of Iowa applicants should refer to this information on UIowa Limited Submissions: https://uiowa.infoready4.com/#competitionDetail/1808614
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
- Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional)
National Institute of General Medical Sciences
- Prodromal a-Synucleinopathies Consortium (PaSS) (U19 Clinical Trial Optional)
National Institute on Aging
National Institute of Neurological Disorders and Stroke
- Network for Identification, Evaluation, and Tracking of Older Persons with Superior Cognitive Performance for Their Chronological Age (U19 Clinical Trial Not Allowed)
National Institute on Aging
- Vaccine and Treatment Evaluation Units (VTEUs): Enhancing Capability and Capacity (UM1 Clinical Trial Required)
(RFA-AI-20-021)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): April 14, 2020
- Implementing the HIV Service Cascade for Justice-Involved Populations (U01 Clinical Trial Required)
(RFA-DA-20-028)
National Institute on Drug Abuse
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below
- FDA's National Curriculum Standard Development and Training Delivery and Development (U18) Clinical Trial Not Allowed FDA's National Curriculum Standard Development and Training Delivery and Development (U18) Clinical Trial Not Allowed
(RFA-FD-20-024)
Food and Drug Administration
- Integrated Pathogen Reduction Technologies for whole blood and blood components for transfusion (R01) Clinical Trial Not Allowed
Food and Drug Administration
- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01) Clinical Trials Required
Food and Drug Administration
- Training Modules to Enhance the Rigor, Reproducibility and Responsible Conduct of Biomedical Data Science Research (R25 - Clinical Trial Not Allowed)
National Institute of General Medical Sciences
National Center for Complementary and Integrative Health
National Institute of Allergy and Infectious Diseases
National Institute of Biomedical Imaging and Bioengineering
National Institute of Dental and Craniofacial Research
National Library of Medicine
- Supporting Primary Care to Advance Cardiovascular Health in States with High Prevalence of Preventable CVD Events (U18)
Agency for Healthcare Research and Quality
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu